Total Payments
$937.64
2022 Payments
$19.04
Companies
22
Transactions
71
Medicare Patients
2,485
Medicare Billing
$426,769
Payment Breakdown by Category
Food & Beverage$894.45 (95.4%)
Education$43.19 (4.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $894.45 | 69 | 95.4% |
| Education | $43.19 | 2 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $150.22 | 17 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $129.98 | 9 | $0 (2020) |
| Amgen Inc. | $103.54 | 8 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $74.02 | 5 | $0 (2018) |
| Celgene Corporation | $67.62 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $64.56 | 5 | $0 (2018) |
| Myovant Sciences Inc. | $52.82 | 3 | $0 (2021) |
| GENZYME CORPORATION | $52.20 | 3 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.68 | 2 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $22.51 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $19.04 | 1 | Siemens Medical Solutions USA, Inc. ($19.04) |
| 2021 | $74.32 | 4 | Myovant Sciences Inc. ($52.82) |
| 2020 | $34.18 | 2 | E.R. Squibb & Sons, L.L.C. ($19.26) |
| 2019 | $182.62 | 13 | GENZYME CORPORATION ($34.91) |
| 2018 | $527.90 | 44 | Janssen Biotech, Inc. ($110.35) |
| 2017 | $99.58 | 7 | Merck Sharp & Dohme Corporation ($26.68) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2022 | Siemens Medical Solutions USA, Inc. | SOMATOM go.Top (Device) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: CT and RO incl. Computed Tomography and Radiation Oncology | ||||||
| 09/10/2021 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 07/08/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Education | In-kind items and services | $23.93 | General |
| Category: HORMONE THERAPY | ||||||
| 07/08/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: HORMONE THERAPY | ||||||
| 02/19/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: HORMONE THERAPY | ||||||
| 09/03/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $19.26 | General |
| Category: Oncology | ||||||
| 02/21/2020 | Boston Scientific Corporation | SPACEOAR (Device) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: BPH | ||||||
| 04/10/2019 | GENZYME CORPORATION | LIBTAYO (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: ONCOLOGY | ||||||
| 04/09/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2019 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Immunology | ||||||
| 03/27/2019 | Janssen Biotech, Inc. | Erleada (Drug), DARZALEX | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Oncology | ||||||
| 03/19/2019 | GENZYME CORPORATION | LIBTAYO (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: ONCOLOGY | ||||||
| 02/18/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Hematology / Oncology | ||||||
| 02/11/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $23.28 | General |
| Category: Oncology | ||||||
| 02/08/2019 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 02/07/2019 | Helsinn Therapeutics (U.S.), Inc. | AKYNZEO (Drug), AKYNZEO | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Oncology | ||||||
| 01/17/2019 | Amgen Inc. | Neulasta (Biological), Vectibix | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Oncology | ||||||
| 01/16/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $10.88 | General |
| Category: Oncology | ||||||
| 01/08/2019 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Oncology | ||||||
| 12/20/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2018 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Oncology | ||||||
| 12/10/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.70 | General |
| Category: Oncology | ||||||
| 11/27/2018 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Oncology | ||||||
| 11/26/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $10.53 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 990 | 2,114 | $608,972 | $150,710 |
| 2022 | 15 | 707 | 1,768 | $578,600 | $126,008 |
| 2021 | 14 | 466 | 1,536 | $702,835 | $93,294 |
| 2020 | 13 | 322 | 1,007 | $452,926 | $56,757 |
Total Patients
2,485
Total Services
6,425
Medicare Billing
$426,769
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 111 | 281 | $168,600 | $41,814 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 110 | 110 | $56,430 | $15,223 | 27.0% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 40 | 43 | $76,626 | $14,148 | 18.5% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 106 | 108 | $42,768 | $13,643 | 31.9% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 56 | 61 | $34,648 | $10,903 | 31.5% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 94 | 215 | $56,760 | $10,305 | 18.2% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 88 | 549 | $41,265 | $8,828 | 21.4% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 88 | 294 | $29,988 | $7,553 | 25.2% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 40 | 43 | $27,950 | $7,543 | 27.0% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 64 | 167 | $17,535 | $5,917 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 45 | 46 | $11,040 | $3,406 | 30.9% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 57 | 82 | $7,216 | $2,417 | 33.5% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 31 | 33 | $8,547 | $2,075 | 24.3% |
| 77768 | High dose skin surface radiation therapy, 2 channels and lesion diameter more than 2.0 cm, or multiple lesions | Facility | 2023 | 13 | 35 | $7,734 | $2,067 | 26.7% |
| 77470 | Special radiation treatment | Facility | 2023 | 21 | 21 | $13,545 | $1,800 | 13.3% |
| 77307 | Complex radiation therapy planning for delivery of external radiation | Facility | 2023 | 13 | 13 | $3,913 | $1,588 | 40.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 13 | $4,407 | $1,478 | 33.5% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 110 | 304 | $225,300 | $46,378 | 20.6% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 40 | 40 | $71,576 | $13,442 | 18.8% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2022 | 78 | 582 | $44,169 | $9,438 | 21.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 63 | 63 | $32,751 | $9,302 | 28.4% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 67 | 67 | $39,519 | $8,926 | 22.6% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2022 | 42 | 44 | $31,984 | $7,872 | 24.6% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 70 | 148 | $42,492 | $7,131 | 16.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 51 | 182 | $19,110 | $6,570 | 34.4% |
About Divya Arora
Divya Arora is a Radiation Oncology healthcare provider based in Gallipolis, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1891053757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Divya Arora has received a total of $937.64 in payments from pharmaceutical and medical device companies, with $19.04 received in 2022. These payments were reported across 71 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($894.45).
As a Medicare-enrolled provider, Arora has provided services to 2,485 Medicare beneficiaries, totaling 6,425 services with total Medicare billing of $426,769. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Gallipolis, OH
- Active Since 04/30/2012
- Last Updated 11/25/2020
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1891053757
Products in Payments
- OPDIVO (Biological) $129.98
- DARZALEX (Biological) $84.50
- ORGOVYX (Drug) $52.82
- KEYTRUDA (Biological) $47.34
- AFINITOR (Drug) $40.32
- Neulasta (Biological) $40.04
- Revlimid (Drug) $36.37
- Kyprolis (Biological) $35.70
- LIBTAYO (Drug) $34.91
- Erleada (Drug) $33.10
- NINLARO (Drug) $24.68
- JADENU (Drug) $24.24
- INJECTAFER (Drug) $21.55
- Udenyca (Biological) $21.50
- SOMATOM go.Top (Device) $19.04
- JEVTANA (Drug) $17.29
- ZYTIGA (Drug) $16.43
- SIMPONI ARIA (Biological) $16.19
- Abraxane (Drug) $15.90
- FOUNDATIONONE (Device) $15.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.